Corridor Pharmaceuticals' Series A Round

Corridor Pharmaceuticals raised a round of funding on June 17, 2010.

Corridor Pharmaceuticals, formerly Arginetix, is a platform-based pulmonary and critical care company focused on developing therapeutics to treat inflammation, fibrosis and endothelial dysfunction. Ut…

Articles about Corridor Pharmaceuticals' Series A Round: